IP waivers on covid jabs will still not be too late3 min read . Updated: 12 Apr 2022, 01:01 AM IST
As a WTO effort to finalize patent waivers on covid-19 vaccines drags on, poorer countries must now take things in their own hands, say public health experts.
Eighteen months after talks began to allow smoother sharing of covid-19 vaccine technologies with developing nations, there’s finally some headway. A draft leaked last month suggests the World Trade Organization (WTO) has brokered a potential waiver from the global patent rules that block such cooperation. But that waiver seems too limited to make a dent, and this experience must push poorer countries to take things in their own hands before the next health emergency strikes, several public health experts told Mint.
Select your Category